Drugplain

AVON HeXashield Triple Antibiotic with Pain Relief 500 [USP'U]/g

BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl · OINTMENT · Tai Guk Pharm. Co., Ltd.

No Recall History
Plain English

AVON HeXashield Triple Antibiotic with Pain Relief is a ointment containing bacitracin zinc, neomycin sulfate, polymyxin b sulfate, pramoxine hcl at 500 [USP'U]/g, taken topical. Manufactured by Tai Guk Pharm. Co., Ltd..

Key Facts

Brand Name
AVON HeXashield Triple Antibiotic with Pain Relief
Generic Name
BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl
NDC Code (Product)
43136-100
Manufacturer
Tai Guk Pharm. Co., Ltd.
Strength
500 [USP'U]/g
Dosage Form
OINTMENT
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
07/31/2019

Recall History

No Recall History

Frequently Asked Questions

What is AVON HeXashield Triple Antibiotic with Pain Relief used for?

AVON HeXashield Triple Antibiotic with Pain Relief contains BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl. It is a ointment taken topical. Consult your doctor for specific uses.

Is AVON HeXashield Triple Antibiotic with Pain Relief a controlled substance?

AVON HeXashield Triple Antibiotic with Pain Relief is not classified as a controlled substance by the DEA.

What is the generic name for AVON HeXashield Triple Antibiotic with Pain Relief?

The generic name for AVON HeXashield Triple Antibiotic with Pain Relief is BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl. There are 2 other brand versions of BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl.

What is the NDC code for AVON HeXashield Triple Antibiotic with Pain Relief 500 [USP'U]/g?

The NDC (National Drug Code) for AVON HeXashield Triple Antibiotic with Pain Relief 500 [USP'U]/g is 43136-100, listed by Tai Guk Pharm. Co., Ltd..

Product NDC

43136-100

Package NDC

43136-100-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)